AI & SEO consulting at MaRS, for health tech and research spinouts.
AI consulting, commercialization support, and digital strategy for MaRS Discovery District tenants: health tech startups, research spinouts, BioLabs University of Toronto residents, and Vector Institute-adjacent teams. Built for the constraints of health, hospital, and academic spinout work.
- Neighbourhood
- MaRS Discovery District
- City
- Toronto, Ontario
The Neighborhood
MaRS Discovery District: Canada's innovation and health-tech anchor
MaRS Discovery District is a place and a project. The place is the MaRS Centre at 101 College Street, at College and University just south of Queen's Park, next to the University of Toronto downtown campus and the hospitals along University Avenue: UHN's Toronto General and Princess Margaret, Sinai Health's Mount Sinai Hospital, and SickKids. The project is a large urban innovation hub, a complex of roughly 1.5 million square feet that houses the Vector Institute for artificial intelligence research, BioLabs University of Toronto (the shared lab incubator that replaced JLABS @ Toronto at the end of 2025), Toronto Innovation Acceleration Partners, and hundreds of early-stage and scaling tenant companies across health, cleantech, AI, fintech, and enterprise software.
The tenant mix is unusual for Canada. The Vector Institute operates from MaRS, which makes the complex a gravity well for Canadian AI research talent. BioLabs University of Toronto gives early-stage life-science, medtech, and digital health startups shared wet-lab space and equipment. Toronto Innovation Acceleration Partners runs hospital-founded commercialization across UHN, Sinai, and the Hospital for Sick Children. Being a short walk from the University Avenue hospitals is a real health-tech translation advantage. Proximity to those hospitals can shorten the path to a first clinical pilot.
What distinguishes MaRS from King West tech (media, agency, growth-stage SaaS) or Bay Street finance (governance-heavy enterprise) is the commercialization stage and the regulatory complexity. MaRS tenants are often pre-revenue or just past it. They are figuring out their first clinical pilot, their first hospital procurement cycle, their first regulatory filing, their first go-to-market messaging. They are also navigating a specific kind of constraint (PHIPA, REB approvals, hospital procurement committees, tech-transfer offices, pharma partnership contracts) that most tech consultants do not understand. That shapes how an engagement with a MaRS tenant is scoped.
Local Pain Points
Pain points specific to MaRS health tech and research spinouts
These are common problems for MaRS tenants, hospital-affiliated spinouts, Vector-adjacent teams, and incubator residents. The common thread is commercialization-stage health tech where scientific credibility is present but operational and go-to-market capacity is thin.
We pick the highest-leverage fix for your MaRS Discovery District business first, not whatever we can bill for longest.
What we hear from MaRS Discovery District operators
- Hospital procurement-friendly positioning: startups with strong science who cannot get past a hospital procurement committee because the materials do not answer the questions those committees actually ask
- Clinical pilot operational tooling: research teams running their first or second UHN or Sinai pilot with consent tracking, site coordination, and data-capture workflows built in a spreadsheet
- Research-operations AI pipelines: literature retrieval, protocol drafting, REB submission drafts, and grant application workflows consuming research-team time that should be on the science
- Go-to-market content for regulated categories: health tech and medtech marketing that has to pass both a procurement review and a regulatory tone check without feeling sterile
- Investor pitch narratives for health-tech specific expectations: MaRS founders pitching to health-focused VCs and pharma corporate venture arms who want different materials than a pure SaaS deck
- Founder operational overhead in a PHIPA-governed environment: CEOs juggling commercialization, regulatory, hospital partnerships, and internal ops with no COO in sight
What we do here
What we build for MaRS tenants and health-tech spinouts
Work for MaRS tenants is narrower and deeper than general tech work, so we are specific about what we do and do not touch. We do not build core clinical AI models or advise on regulatory affairs. We do build the commercialization layer around science-led teams: positioning, hospital procurement materials, research-operations AI, and the investor narrative that gets funded.
Looking for city-wide services?
Broader Toronto service pages
This page covers the MaRS Discovery District picture specifically. If you want the full scope of how we work across Toronto, head to the city-level pages below.
Industries
Industries we serve in MaRS Discovery District
A deeper industry view, including case studies and specific workflows we have built.
FAQ
Common questions from MaRS Discovery District businesses
The highest-leverage early work for MaRS health tech startups is usually in two places: clinical-workflow validation (how the AI fits into a real clinician's day without violating scope-of-practice or privacy rules) and research-operations tooling (retrieval over literature, protocol drafting, REB submission drafts). We do not build the core clinical model. That is your research team's job. We build the operational layer around it, plus the go-to-market content and positioning that hospital procurement committees actually need to see.
A MaRS health tech engagement starts with a privacy-and-data-residency scope call. PHIPA-governed workflows do not touch consumer AI. We design with de-identified data where possible, route through Canadian-region Azure or AWS infrastructure, work with hospital IT on data-residency constraints, and respect the REB approvals you already have. If you are a startup coming out of a UHN or Sinai Health incubation, we coordinate with your host-institution tech transfer and privacy office.
Our fit with Vector-affiliated and academic AI research teams is narrow but specific: we do not advise on foundation-model research. That work belongs inside Vector and the University of Toronto. Where we add value is on the commercialization layer: research spinouts that need to package their work for first customers, hospital procurement, or enterprise pilots. The science is yours. The packaging, the positioning, and the operational rollout is where we help.
Early-stage medtech and digital health teams, including residents of BioLabs University of Toronto (the shared lab incubator at MaRS that replaced JLABS @ Toronto after Johnson & Johnson withdrew its support at the end of 2025), often have strong science and thin go-to-market and operational tooling. That is where we can help: investor-pitch content, hospital procurement-friendly positioning materials, clinical pilot operational workflows (consent tracking, site coordination, data capture), and the AI-assisted research-operations pipelines that let small research teams operate like bigger ones.
Other Toronto neighborhoods
Explore the rest of Toronto
Ready to commercialize your MaRS-tenant health tech or research spinout?
Book a free 30-minute call. We will scope the commercialization gap honestly (hospital procurement, research operations, investor narrative, or all three) and tell you whether we are the right fit. Serving MaRS Discovery District and the rest of Toronto, Ontario.